Phase 2
-
Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
Phase 2 · randomised · 50 people · 1 site in China · Recruiting now
-
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Phase 2 · randomised · 245 people · 17 sites in 5 countries · Recruiting now
-
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 2 · 134 people · 8 sites in United States · Recruiting now
-
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
Phase 2 · 15 people · 1 site in United States · Recruiting now
-
Single cEll pRofiling PErsistaNce To ImmuNothErapy
Phase 2 · 60 people · 1 site in Spain · Recruiting now
-
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
Phase 2 · 44 people · 3 sites in United States · Recruiting now